VXRT
Vaxart, Inc.Company with tickers: VXRT
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
76
Net buyers
+1
Net shares bought
0.00%
Net buy value
+$6,530
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2033-03-17 | Lee Phillip E |
Chief Financial Officer | Award | 410,000 |
| 2026-05-22 | Watson W. Mark |
Director | Buy | 10,000 |
| 2026-05-19 | Grasman Jeroen Nicolaas |
Chief Financial Officer | Tax | 31,395 |
| 2026-04-23 | BREITMEYER JAMES B |
Director | Other | 0 |
| 2026-04-23 | BREITMEYER JAMES B |
Director | Award | 78,800 |
| 2026-04-23 | BREITMEYER JAMES B |
Director | Award | 157,400 |
| 2026-03-28 | Tucker Sean |
SVP, Chief Scientific Officer | Tax | 3,924 |
| 2026-03-28 | Cummings James F. |
Chief Medical Officer | Tax | 3,292 |
| 2026-03-24 | Cummings James F. |
Chief Medical Officer | Tax | 30,551 |
| 2026-03-24 | Lo Steven |
Director, President, Chief Exec Officer | Tax | 126,028 |
| 2026-03-24 | Berg Edward B |
SVP, General Counsel | Tax | 36,418 |
| 2026-03-24 | Tucker Sean |
SVP, Chief Scientific Officer | Tax | 36,418 |
| 2026-03-18 | Cummings James F. |
Chief Medical Officer | Tax | 6,772 |
| 2026-03-18 | Berg Edward B |
SVP, General Counsel | Tax | 8,072 |
| 2026-03-18 | Tucker Sean |
SVP, Chief Scientific Officer | Tax | 8,072 |
| 2026-03-18 | Lo Steven |
Director, President, Chief Exec Officer | Tax | 22,425 |
| 2026-03-16 | Tucker Sean |
SVP, Chief Scientific Officer | Award | 200,000 |
| 2026-03-16 | Cummings James F. |
Chief Medical Officer | Award | 455,000 |
| 2026-03-16 | Tucker Sean |
SVP, Chief Scientific Officer | Award | 410,000 |
| 2026-03-16 | Cummings James F. |
Chief Medical Officer | Award | 227,000 |
| 2026-03-16 | Lo Steven |
Director, President, Chief Exec Officer | Award | 846,500 |
| 2026-03-16 | Grasman Jeroen Nicolaas |
Chief Financial Officer | Award | 455,000 |
| 2026-03-16 | Berg Edward B |
SVP, General Counsel | Award | 115,000 |
| 2026-03-16 | Grasman Jeroen Nicolaas |
Chief Financial Officer | Award | 227,000 |
| 2026-03-16 | Berg Edward B |
SVP, General Counsel | Award | 225,000 |
| 2026-03-16 | Lo Steven |
Director, President, Chief Exec Officer | Award | 1,543,000 |
| 2026-02-02 | Berg Edward B |
SVP, General Counsel | Tax | 9,265 |
| 2026-02-02 | Cummings James F. |
Chief Medical Officer | Tax | 7,965 |
| 2026-02-02 | Tucker Sean |
SVP, Chief Scientific Officer | Tax | 9,265 |
| 2025-12-04 | Lo Steven |
Director, President, Chief Exec Officer | Award | 151,351 |
| 2025-12-04 | Lo Steven |
Director, President, Chief Exec Officer | Tax | 54,153 |
| 2025-11-17 | Watson W. Mark |
Director | Buy | 15,000 |
| 2025-11-17 | HERON ELAINE J |
Director | Buy | 16,783 |
| 2025-11-17 | HERON ELAINE J |
Director | Buy | 23,217 |
| 2025-11-17 | Watson W. Mark |
Director | Buy | 5,000 |
| 2025-08-15 | Finney Kevin |
Director | Buy | 50,000 |
| 2025-08-15 | Finney Kevin |
Director | Buy | 50,000 |
| 2025-07-30 | Finney Kevin |
Director | Buy | 25,874 |
| 2025-07-29 | Watson W. Mark |
Director | Buy | 10,000 |
| 2025-07-28 | Finney Kevin |
Director | Buy | 20,000 |
| 2025-07-25 | Finney Kevin |
Director | Buy | 20,000 |
| 2025-07-17 | Finney Kevin |
Director | Buy | 794 |
| 2025-06-13 | HERON ELAINE J |
Director | Award | 16,000 |
| 2025-06-13 | Finney Michael J. |
Director | Award | 16,000 |
| 2025-06-13 | Wheadon David E. |
Director | Award | 95,400 |
| 2025-06-13 | Finney Michael J. |
Director | Award | 95,400 |
| 2025-06-13 | Finney Kevin |
Director | Award | 6,103 |
| 2025-06-13 | HERON ELAINE J |
Director | Award | 95,400 |
| 2025-06-13 | Wheadon David E. |
Director | Award | 16,000 |
| 2025-06-13 | Watson W. Mark |
Director | Award | 16,000 |
Showing 1–50 of 333 transactions